| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | 1.14e-07 | 884 | 21 | 9 | GO:0004930 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | 3.49e-07 | 1353 | 21 | 10 | GO:0004888 | |
| GeneOntologyMolecularFunction | somatostatin receptor activity | 1.05e-05 | 5 | 21 | 2 | GO:0004994 | |
| GeneOntologyMolecularFunction | G-protein alpha-subunit binding | 1.20e-05 | 43 | 21 | 3 | GO:0001965 | |
| GeneOntologyMolecularFunction | neuropeptide receptor activity | 2.27e-05 | 53 | 21 | 3 | GO:0008188 | |
| GeneOntologyMolecularFunction | ATPase binding | 1.91e-04 | 108 | 21 | 3 | GO:0051117 | |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 3.52e-04 | 133 | 21 | 3 | GO:0008528 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 4.09e-04 | 140 | 21 | 3 | GO:0001653 | |
| GeneOntologyMolecularFunction | neuropeptide binding | 6.86e-04 | 37 | 21 | 2 | GO:0042923 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 3.49e-03 | 614 | 21 | 4 | GO:0140657 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 4.62e-03 | 664 | 21 | 4 | GO:0008324 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 4.90e-03 | 100 | 21 | 2 | GO:0030594 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 5.79e-03 | 109 | 21 | 2 | GO:0042626 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | 6.57e-03 | 1180 | 21 | 5 | GO:0022857 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 8.61e-03 | 793 | 21 | 4 | GO:0015075 | |
| GeneOntologyMolecularFunction | transporter activity | 9.49e-03 | 1289 | 21 | 5 | GO:0005215 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 1.06e-02 | 441 | 21 | 3 | GO:0016887 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 1.31e-02 | 477 | 21 | 3 | GO:0022804 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 1.48e-02 | 178 | 21 | 2 | GO:0015399 | |
| GeneOntologyBiologicalProcess | phospholipase C-activating G protein-coupled receptor signaling pathway | 1.94e-07 | 133 | 21 | 5 | GO:0007200 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | 3.99e-07 | 61 | 21 | 4 | GO:0007187 | |
| GeneOntologyBiologicalProcess | response to abiotic stimulus | 3.29e-06 | 1361 | 21 | 9 | GO:0009628 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | 4.03e-06 | 1395 | 21 | 9 | GO:0007186 | |
| GeneOntologyBiologicalProcess | calcium ion transport | 8.68e-06 | 509 | 21 | 6 | GO:0006816 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | 1.01e-05 | 1157 | 21 | 8 | GO:0006812 | |
| GeneOntologyBiologicalProcess | somatostatin receptor signaling pathway | 1.48e-05 | 6 | 21 | 2 | GO:0038169 | |
| GeneOntologyBiologicalProcess | somatostatin signaling pathway | 1.48e-05 | 6 | 21 | 2 | GO:0038170 | |
| GeneOntologyBiologicalProcess | cellular response to organic cyclic compound | 2.31e-05 | 605 | 21 | 6 | GO:0071407 | |
| GeneOntologyBiologicalProcess | intracellular monoatomic cation homeostasis | 2.45e-05 | 611 | 21 | 6 | GO:0030003 | |
| GeneOntologyBiologicalProcess | intracellular calcium ion homeostasis | 2.51e-05 | 359 | 21 | 5 | GO:0006874 | |
| GeneOntologyBiologicalProcess | intracellular monoatomic ion homeostasis | 2.71e-05 | 622 | 21 | 6 | GO:0006873 | |
| GeneOntologyBiologicalProcess | regulation of ERK1 and ERK2 cascade | 3.51e-05 | 385 | 21 | 5 | GO:0070372 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | 3.53e-05 | 1374 | 21 | 8 | GO:0006811 | |
| GeneOntologyBiologicalProcess | calcium ion homeostasis | 3.69e-05 | 389 | 21 | 5 | GO:0055074 | |
| GeneOntologyBiologicalProcess | ERK1 and ERK2 cascade | 5.19e-05 | 418 | 21 | 5 | GO:0070371 | |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | 5.46e-05 | 705 | 21 | 6 | GO:0055080 | |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | 5.99e-05 | 717 | 21 | 6 | GO:0050801 | |
| GeneOntologyBiologicalProcess | positive regulation of transport | 6.47e-05 | 1081 | 21 | 7 | GO:0051050 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | 7.88e-05 | 1115 | 21 | 7 | GO:0034220 | |
| GeneOntologyBiologicalProcess | positive regulation of ERK1 and ERK2 cascade | 9.16e-05 | 240 | 21 | 4 | GO:0070374 | |
| GeneOntologyBiologicalProcess | gastro-intestinal system smooth muscle contraction | 1.03e-04 | 15 | 21 | 2 | GO:0014831 | |
| GeneOntologyBiologicalProcess | regulation of MAPK cascade | 1.22e-04 | 815 | 21 | 6 | GO:0043408 | |
| GeneOntologyBiologicalProcess | chemical homeostasis | 1.61e-04 | 1249 | 21 | 7 | GO:0048878 | |
| GeneOntologyBiologicalProcess | negative regulation of endoplasmic reticulum unfolded protein response | 1.67e-04 | 19 | 21 | 2 | GO:1900102 | |
| GeneOntologyBiologicalProcess | intracellular chemical homeostasis | 1.70e-04 | 866 | 21 | 6 | GO:0055082 | |
| GeneOntologyBiologicalProcess | positive regulation of MAPK cascade | 2.25e-04 | 571 | 21 | 5 | GO:0043410 | |
| GeneOntologyBiologicalProcess | vasoconstriction | 2.42e-04 | 121 | 21 | 3 | GO:0042310 | |
| GeneOntologyBiologicalProcess | positive regulation of T-helper 17 type immune response | 2.47e-04 | 23 | 21 | 2 | GO:2000318 | |
| GeneOntologyBiologicalProcess | MAPK cascade | 2.50e-04 | 930 | 21 | 6 | GO:0000165 | |
| GeneOntologyBiologicalProcess | positive regulation of cytokine production | 2.54e-04 | 586 | 21 | 5 | GO:0001819 | |
| GeneOntologyBiologicalProcess | neuropeptide signaling pathway | 2.61e-04 | 124 | 21 | 3 | GO:0007218 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | 2.68e-04 | 942 | 21 | 6 | GO:0098655 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion transport | 2.86e-04 | 323 | 21 | 4 | GO:0051924 | |
| GeneOntologyBiologicalProcess | smooth muscle contraction | 3.20e-04 | 133 | 21 | 3 | GO:0006939 | |
| GeneOntologyBiologicalProcess | cellular homeostasis | 3.34e-04 | 981 | 21 | 6 | GO:0019725 | |
| GeneOntologyBiologicalProcess | inorganic ion homeostasis | 3.34e-04 | 622 | 21 | 5 | GO:0098771 | |
| GeneOntologyBiologicalProcess | metal ion transport | 3.70e-04 | 1000 | 21 | 6 | GO:0030001 | |
| GeneOntologyBiologicalProcess | regulation of cytokine production | 3.91e-04 | 1010 | 21 | 6 | GO:0001817 | |
| GeneOntologyBiologicalProcess | blood circulation | 4.04e-04 | 648 | 21 | 5 | GO:0008015 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | 4.05e-04 | 1017 | 21 | 6 | GO:0098660 | |
| GeneOntologyBiologicalProcess | phasic smooth muscle contraction | 4.22e-04 | 30 | 21 | 2 | GO:0014821 | |
| GeneOntologyBiologicalProcess | chemosensory behavior | 4.51e-04 | 31 | 21 | 2 | GO:0007635 | |
| GeneOntologyBiologicalProcess | response to organic cyclic compound | 4.76e-04 | 1048 | 21 | 6 | GO:0014070 | |
| GeneOntologyBiologicalProcess | cellular response to abiotic stimulus | 4.84e-04 | 371 | 21 | 4 | GO:0071214 | |
| GeneOntologyBiologicalProcess | cellular response to environmental stimulus | 4.84e-04 | 371 | 21 | 4 | GO:0104004 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transport | 4.92e-04 | 154 | 21 | 3 | GO:0051928 | |
| GeneOntologyBiologicalProcess | regulation of endoplasmic reticulum unfolded protein response | 5.43e-04 | 34 | 21 | 2 | GO:1900101 | |
| GeneOntologyBiologicalProcess | cytokine production | 5.90e-04 | 1091 | 21 | 6 | GO:0001816 | |
| GeneOntologyBiologicalProcess | detection of stimulus | 6.61e-04 | 722 | 21 | 5 | GO:0051606 | |
| GeneOntologyBiologicalProcess | defense response to bacterium | 6.73e-04 | 405 | 21 | 4 | GO:0042742 | |
| GeneOntologyBiologicalProcess | detection of external stimulus | 6.90e-04 | 173 | 21 | 3 | GO:0009581 | |
| GeneOntologyBiologicalProcess | response to lipid | 6.97e-04 | 1126 | 21 | 6 | GO:0033993 | |
| GeneOntologyBiologicalProcess | circulatory system process | 7.08e-04 | 733 | 21 | 5 | GO:0003013 | |
| GeneOntologyBiologicalProcess | detection of abiotic stimulus | 7.14e-04 | 175 | 21 | 3 | GO:0009582 | |
| GeneOntologyBiologicalProcess | cellular response to lipid | 7.76e-04 | 748 | 21 | 5 | GO:0071396 | |
| GeneOntologyBiologicalProcess | regulation of T-helper 17 type immune response | 1.04e-03 | 47 | 21 | 2 | GO:2000316 | |
| GeneOntologyBiologicalProcess | blood vessel diameter maintenance | 1.08e-03 | 202 | 21 | 3 | GO:0097746 | |
| GeneOntologyBiologicalProcess | regulation of tube diameter | 1.08e-03 | 202 | 21 | 3 | GO:0035296 | |
| GeneOntologyBiologicalProcess | regulation of tube size | 1.10e-03 | 203 | 21 | 3 | GO:0035150 | |
| GeneOntologyBiologicalProcess | negative regulation of response to endoplasmic reticulum stress | 1.13e-03 | 49 | 21 | 2 | GO:1903573 | |
| GeneOntologyBiologicalProcess | ER-nucleus signaling pathway | 1.32e-03 | 53 | 21 | 2 | GO:0006984 | |
| GeneOntologyBiologicalProcess | response to nitrogen compound | 1.32e-03 | 1272 | 21 | 6 | GO:1901698 | |
| GeneOntologyBiologicalProcess | positive regulation of immune response | 1.34e-03 | 845 | 21 | 5 | GO:0050778 | |
| GeneOntologyBiologicalProcess | regulation of metal ion transport | 1.40e-03 | 493 | 21 | 4 | GO:0010959 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular signal transduction | 1.47e-03 | 1299 | 21 | 6 | GO:1902533 | |
| GeneOntologyBiologicalProcess | regulation of response to external stimulus | 1.58e-03 | 1316 | 21 | 6 | GO:0032101 | |
| GeneOntologyBiologicalProcess | response to amine | 1.58e-03 | 58 | 21 | 2 | GO:0014075 | |
| GeneOntologyBiologicalProcess | behavior | 1.70e-03 | 891 | 21 | 5 | GO:0007610 | |
| GeneOntologyBiologicalProcess | sensory perception of mechanical stimulus | 1.73e-03 | 238 | 21 | 3 | GO:0050954 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion import | 1.74e-03 | 61 | 21 | 2 | GO:0090279 | |
| GeneOntologyBiologicalProcess | T-helper 17 type immune response | 1.92e-03 | 64 | 21 | 2 | GO:0072538 | |
| GeneOntologyBiologicalProcess | cellular response to dopamine | 1.92e-03 | 64 | 21 | 2 | GO:1903351 | |
| GeneOntologyBiologicalProcess | response to bacterium | 1.92e-03 | 916 | 21 | 5 | GO:0009617 | |
| GeneOntologyBiologicalProcess | circadian rhythm | 1.95e-03 | 248 | 21 | 3 | GO:0007623 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | 1.97e-03 | 922 | 21 | 5 | GO:0098662 | |
| GeneOntologyBiologicalProcess | response to dopamine | 2.04e-03 | 66 | 21 | 2 | GO:1903350 | |
| GeneOntologyBiologicalProcess | cellular response to monoamine stimulus | 2.16e-03 | 68 | 21 | 2 | GO:0071868 | |
| GeneOntologyBiologicalProcess | cellular response to catecholamine stimulus | 2.16e-03 | 68 | 21 | 2 | GO:0071870 | |
| GeneOntologyBiologicalProcess | response to fatty acid | 2.22e-03 | 69 | 21 | 2 | GO:0070542 | |
| GeneOntologyBiologicalProcess | calcium-mediated signaling | 2.38e-03 | 266 | 21 | 3 | GO:0019722 | |
| GeneOntologyBiologicalProcess | positive regulation of monoatomic ion transport | 2.38e-03 | 266 | 21 | 3 | GO:0043270 | |
| HumanPheno | Polydipsia | 7.09e-07 | 53 | 8 | 4 | HP:0001959 | |
| HumanPheno | Abnormal drinking behavior | 3.96e-06 | 81 | 8 | 4 | HP:0030082 | |
| HumanPheno | Progressive sensorineural hearing impairment | 7.15e-05 | 57 | 8 | 3 | HP:0000408 | |
| HumanPheno | Reduced impulse control | 9.08e-05 | 1032 | 8 | 7 | HP:5200045 | |
| HumanPheno | Progressive hearing impairment | 1.01e-04 | 64 | 8 | 3 | HP:0001730 | |
| MousePheno | increased acute inflammation | 6.17e-05 | 164 | 19 | 4 | MP:0005088 | |
| MousePheno | abnormal hypersensitivity reaction | 7.77e-05 | 174 | 19 | 4 | MP:0002148 | |
| MousePheno | abnormal acute inflammation | 9.14e-05 | 357 | 19 | 5 | MP:0002498 | |
| MousePheno | abnormal T-helper 2 physiology | 9.65e-05 | 67 | 19 | 3 | MP:0005466 | |
| MousePheno | decreased susceptibility to experimental autoimmune encephalomyelitis | 1.83e-04 | 83 | 19 | 3 | MP:0004800 | |
| Domain | GPCR_Rhodpsn_7TM | 3.54e-07 | 670 | 21 | 8 | IPR017452 | |
| Domain | 7tm_1 | 3.83e-07 | 677 | 21 | 8 | PF00001 | |
| Domain | G_PROTEIN_RECEP_F1_1 | 4.19e-07 | 685 | 21 | 8 | PS00237 | |
| Domain | G_PROTEIN_RECEP_F1_2 | 4.47e-07 | 691 | 21 | 8 | PS50262 | |
| Domain | GPCR_Rhodpsn | 4.52e-07 | 692 | 21 | 8 | IPR000276 | |
| Domain | PYRIN | 1.86e-06 | 22 | 21 | 3 | SM01289 | |
| Domain | DAPIN | 1.86e-06 | 22 | 21 | 3 | PS50824 | |
| Domain | DAPIN | 1.86e-06 | 22 | 21 | 3 | IPR004020 | |
| Domain | PYRIN | 1.86e-06 | 22 | 21 | 3 | PF02758 | |
| Domain | NACHT | 2.14e-06 | 23 | 21 | 3 | PS50837 | |
| Domain | NACHT_NTPase | 2.14e-06 | 23 | 21 | 3 | IPR007111 | |
| Domain | 7TM_GPCR_Srsx | 6.78e-06 | 112 | 21 | 4 | SM01381 | |
| Domain | Somatstn_rcpt | 1.20e-05 | 5 | 21 | 2 | IPR000586 | |
| Domain | - | 1.49e-04 | 93 | 21 | 3 | 1.10.533.10 | |
| Domain | DEATH-like_dom | 1.79e-04 | 99 | 21 | 3 | IPR011029 | |
| Domain | LRR_6 | 1.72e-03 | 55 | 21 | 2 | PF13516 | |
| Domain | P-loop_NTPase | 1.36e-02 | 848 | 21 | 4 | IPR027417 | |
| Pathway | WP_GPCRS_NONODORANT | 5.65e-12 | 266 | 17 | 9 | MM15843 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | 4.12e-10 | 430 | 17 | 9 | MM15160 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | 7.92e-10 | 463 | 17 | 9 | M507 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 1.68e-09 | 330 | 17 | 8 | M18334 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 1.80e-09 | 333 | 17 | 8 | MM14963 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 1.11e-08 | 260 | 17 | 7 | M39397 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | 1.47e-08 | 646 | 17 | 9 | MM14962 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | 3.04e-08 | 702 | 17 | 9 | M746 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 5.34e-08 | 186 | 17 | 6 | MM15994 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 5.06e-07 | 272 | 17 | 6 | M13380 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | 1.77e-05 | 289 | 17 | 5 | MM15057 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | 2.64e-05 | 314 | 17 | 5 | M600 | |
| Pathway | WP_GPCRS_PEPTIDE | 7.59e-05 | 70 | 17 | 3 | MM15959 | |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | 7.63e-05 | 197 | 17 | 4 | MM14970 | |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | 7.63e-05 | 197 | 17 | 4 | M12289 | |
| Pathway | WP_PEPTIDE_GPCRS | 9.32e-05 | 75 | 17 | 3 | M39696 | |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | 9.78e-05 | 210 | 17 | 4 | MM15043 | |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | 1.11e-04 | 217 | 17 | 4 | M18437 | |
| Pathway | REACTOME_PURINERGIC_SIGNALING_IN_LEISHMANIASIS_INFECTION | 4.37e-04 | 26 | 17 | 2 | M29838 | |
| Pathway | WP_MONOAMINE_GPCRS | 6.24e-04 | 31 | 17 | 2 | MM15871 | |
| Pathway | WP_MONOAMINE_GPCRS | 7.07e-04 | 33 | 17 | 2 | M39585 | |
| Pathway | WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY | 1.09e-03 | 41 | 17 | 2 | M39698 | |
| Pathway | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | 1.15e-03 | 42 | 17 | 2 | MM14971 | |
| Pathway | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | 1.15e-03 | 42 | 17 | 2 | M5868 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 1.18e-03 | 178 | 17 | 3 | M2890 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GPCR_PLCB_ITPR_SIGNALING_PATHWAY | 1.62e-03 | 50 | 17 | 2 | M47951 | |
| Pathway | WP_CIRCADIAN_RHYTHM_GENES | 1.68e-03 | 201 | 17 | 3 | M39605 | |
| Pathway | KEGG_GAP_JUNCTION | 5.15e-03 | 90 | 17 | 2 | M4013 | |
| Pathway | WP_GPCRS_OTHER | 5.84e-03 | 96 | 17 | 2 | MM15939 | |
| Pubmed | 1.69e-09 | 200 | 21 | 6 | 18240029 | ||
| Pubmed | NODs: intracellular proteins involved in inflammation and apoptosis. | 4.16e-08 | 12 | 21 | 3 | 12766759 | |
| Pubmed | 6.50e-08 | 179 | 21 | 5 | 18577758 | ||
| Pubmed | 6.88e-08 | 14 | 21 | 3 | 20403135 | ||
| Pubmed | 6.88e-08 | 14 | 21 | 3 | 12563287 | ||
| Pubmed | Stable association between G alpha(q) and phospholipase C beta 1 in living cells. | 3.02e-07 | 95 | 21 | 4 | 16754659 | |
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 29345311 | ||
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 23271661 | ||
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 39218048 | ||
| Pubmed | 2.08e-06 | 4 | 21 | 2 | 10996426 | ||
| Pubmed | NLRP10 is a NOD-like receptor essential to initiate adaptive immunity by dendritic cells. | 2.08e-06 | 4 | 21 | 2 | 22538615 | |
| Pubmed | 2.08e-06 | 4 | 21 | 2 | 8405411 | ||
| Pubmed | 3.47e-06 | 5 | 21 | 2 | 11897118 | ||
| Pubmed | Cutting edge: the NLRP3 inflammasome links complement-mediated inflammation and IL-1β release. | 3.47e-06 | 5 | 21 | 2 | 23817414 | |
| Pubmed | 3.47e-06 | 5 | 21 | 2 | 12021920 | ||
| Pubmed | 3.47e-06 | 5 | 21 | 2 | 18936524 | ||
| Pubmed | The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP. | 3.47e-06 | 5 | 21 | 2 | 23143333 | |
| Pubmed | 3.47e-06 | 5 | 21 | 2 | 11753241 | ||
| Pubmed | 3.47e-06 | 5 | 21 | 2 | 8449518 | ||
| Pubmed | Somatostatin receptor subtype gene expression in human endocrine gastroentero-pancreatic tumours. | 3.47e-06 | 5 | 21 | 2 | 9279525 | |
| Pubmed | 3.47e-06 | 5 | 21 | 2 | 25962406 | ||
| Pubmed | 3.47e-06 | 5 | 21 | 2 | 11344221 | ||
| Pubmed | 3.47e-06 | 5 | 21 | 2 | 12759718 | ||
| Pubmed | 3.47e-06 | 5 | 21 | 2 | 19330452 | ||
| Pubmed | 3.47e-06 | 5 | 21 | 2 | 12414882 | ||
| Pubmed | Interaction of brain somatostatin receptors with the PDZ domains of PSD-95. | 3.47e-06 | 5 | 21 | 2 | 17950729 | |
| Pubmed | Prognostic Value of Somatostatin Receptor Subtypes in Pancreatic Neuroendocrine Tumors. | 3.47e-06 | 5 | 21 | 2 | 26474434 | |
| Pubmed | Somatostatin receptor subtypes in human type 2 diabetic islets. | 3.47e-06 | 5 | 21 | 2 | 20182388 | |
| Pubmed | 3.47e-06 | 5 | 21 | 2 | 20717067 | ||
| Pubmed | Brain somatostatin receptors are up-regulated in somatostatin-deficient mice. | 5.20e-06 | 6 | 21 | 2 | 12145348 | |
| Pubmed | Identification and characterization of a novel human cortistatin-like peptide. | 5.20e-06 | 6 | 21 | 2 | 9125122 | |
| Pubmed | Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome. | 5.20e-06 | 6 | 21 | 2 | 25594175 | |
| Pubmed | Cloning, mRNA expression, and chromosomal mapping of mouse and human preprocortistatin. | 5.20e-06 | 6 | 21 | 2 | 9205124 | |
| Pubmed | 5.20e-06 | 6 | 21 | 2 | 19423539 | ||
| Pubmed | 5.20e-06 | 6 | 21 | 2 | 1346068 | ||
| Pubmed | 7.28e-06 | 7 | 21 | 2 | 25149275 | ||
| Pubmed | Structural, expression, and evolutionary analysis of mouse CIAS1. | 7.28e-06 | 7 | 21 | 2 | 15302403 | |
| Pubmed | Null mutant mouse models of somatostatin and cortistatin, and their receptors. | 7.28e-06 | 7 | 21 | 2 | 18206294 | |
| Pubmed | 7.28e-06 | 7 | 21 | 2 | 22581439 | ||
| Pubmed | 7.28e-06 | 7 | 21 | 2 | 15817483 | ||
| Pubmed | 1.56e-05 | 10 | 21 | 2 | 16214911 | ||
| Pubmed | 1.75e-05 | 84 | 21 | 3 | 15123239 | ||
| Pubmed | A large-scale candidate gene association study of age at menarche and age at natural menopause. | 2.06e-05 | 275 | 21 | 4 | 20734064 | |
| Pubmed | NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. | 2.28e-05 | 12 | 21 | 2 | 21565393 | |
| Pubmed | Deficient IFN signaling by myeloid cells leads to MAVS-dependent virus-induced sepsis. | 2.28e-05 | 12 | 21 | 2 | 24743949 | |
| Pubmed | 2.89e-05 | 300 | 21 | 4 | 19086053 | ||
| Pubmed | Systematic protein-protein interaction mapping for clinically relevant human GPCRs. | 4.97e-05 | 697 | 21 | 5 | 28298427 | |
| Pubmed | 5.28e-05 | 18 | 21 | 2 | 20810604 | ||
| Pubmed | PTEN identified as important risk factor of chronic obstructive pulmonary disease. | 6.81e-05 | 374 | 21 | 4 | 19625176 | |
| Pubmed | 7.32e-05 | 381 | 21 | 4 | 18676680 | ||
| Pubmed | Polymorphisms in innate immunity genes and lung cancer risk in Xuanwei, China. | 7.40e-05 | 382 | 21 | 4 | 19170196 | |
| Pubmed | 7.96e-05 | 22 | 21 | 2 | 33821423 | ||
| Pubmed | Genetic susceptibility to distinct bladder cancer subphenotypes. | 1.08e-04 | 421 | 21 | 4 | 19692168 | |
| Pubmed | 1.12e-04 | 26 | 21 | 2 | 9226367 | ||
| Interaction | SST interactions | 3.71e-05 | 9 | 21 | 2 | int:SST | |
| Interaction | SNTA1 interactions | 1.71e-04 | 105 | 21 | 3 | int:SNTA1 | |
| Interaction | HTR3A interactions | 1.86e-04 | 108 | 21 | 3 | int:HTR3A | |
| Interaction | CORT interactions | 2.15e-04 | 21 | 21 | 2 | int:CORT | |
| Interaction | KIAA2013 interactions | 2.29e-04 | 116 | 21 | 3 | int:KIAA2013 | |
| GeneFamily | Pyrin domain containing|Pyrin and HIN domain family | 1.88e-06 | 25 | 18 | 3 | 994 | |
| GeneFamily | NLR family | 1.88e-06 | 25 | 18 | 3 | 666 | |
| GeneFamily | Somatostatin receptors | 9.35e-06 | 5 | 18 | 2 | 257 | |
| CoexpressionAtlas | Myeloid Cells, DC.103-11b+24-.Lu, MHCII+ CD11c+ CD103- CD11b+ CD24-, Lung, avg-2 | 5.82e-05 | 81 | 20 | 3 | GSM854271_100 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Nxph3|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.87e-07 | 138 | 21 | 4 | b63e26afafbd2cdeed9c9451e6f530ab6295504c | |
| ToppCell | Frontal_cortex-Hematopoietic-MICROGLIA-MI1(C1qb)-Tmem119|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.76e-05 | 140 | 21 | 3 | 2c04fa782aa076e4be8a2781aa04231180bd69bd | |
| ToppCell | Frontal_cortex-Hematopoietic-MICROGLIA-MI1(C1qb)-Tmem119-MICROGLIA_Microglia.C1qb.Tmem119-Fos_(Microglia.C1qb.Tmem119-Fos)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.76e-05 | 140 | 21 | 3 | a9389a6e55d02d5037868c9ecce48b5e8d7c2902 | |
| ToppCell | Frontal_cortex-Hematopoietic-MICROGLIA-MI1(C1qb)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.76e-05 | 140 | 21 | 3 | 8db98a17a4d4b42dbfc75e9cdaa22275fed4f2f0 | |
| ToppCell | Frontal_cortex-Hematopoietic-MICROGLIA-MI1(C1qb)-Tmem119-MICROGLIA_Microglia.C1qb.Tmem119-Fos_(Microglia.C1qb.Tmem119-Fos)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.76e-05 | 140 | 21 | 3 | 22098203361f61b9f0ce9f0f2d1369d8bb1379a8 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Monocytic-Cycling_mono|bone_marrow / Manually curated celltypes from each tissue | 4.44e-05 | 148 | 21 | 3 | de35eeefad0e27a0d127e2e4bedead2bddb75152 | |
| ToppCell | frontal_cortex-Non-neuronal-macrophage-Macrophage-PVM_Mrc1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.44e-05 | 148 | 21 | 3 | d3ea907f8f408e9bb97ed223a3089e403e35f911 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Hematologic-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.44e-05 | 148 | 21 | 3 | 7c7c87b57aa16f8b91698489df39ace5a3a53df8 | |
| ToppCell | Hippocampus-Hematopoietic|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.71e-05 | 151 | 21 | 3 | 81b2189afd72658f7e2539b856ba79cd49340215 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Myeloid|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.00e-05 | 154 | 21 | 3 | 12d3ecb0c4d814a91ac833fcb74db6b9dbc0a321 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Myeloid-macrophage|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.00e-05 | 154 | 21 | 3 | 64192a0f78021551886bbaf929916392bce451c0 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Myeloid-macrophage|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.00e-05 | 154 | 21 | 3 | 93ace0a42f3ea94605b13acd79659602b3a31b74 | |
| ToppCell | facs-MAT-Fat-24m-Myeloid-macrophage|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.10e-05 | 155 | 21 | 3 | d0c1608f8f6b6f4174e51d610501c707cba5e015 | |
| ToppCell | Globus_pallidus-Hematopoietic|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 5.19e-05 | 156 | 21 | 3 | 67cdaadc3b917f7072adce16c0391472c14a2563 | |
| ToppCell | droplet-Kidney-nan-18m-Myeloid-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-05 | 157 | 21 | 3 | eb64a4e89843895d16015c7d51805f164ed7ea5b | |
| ToppCell | Frontal_cortex-Hematopoietic-MICROGLIA|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.50e-05 | 159 | 21 | 3 | 41d2c1e71f6983156f8cc8ec5f69e025e5700f46 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Type_1_alveolar|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.60e-05 | 160 | 21 | 3 | 58ed3a074932ccc951e07868dfdc61b99ae1cc2b | |
| ToppCell | Frontal_cortex-Hematopoietic|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.60e-05 | 160 | 21 | 3 | 70ffbe61cfd729519b23569a43d929b117ab8d5e | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Myeloid|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.71e-05 | 161 | 21 | 3 | 3db97af49520dc8cbafb4454d8afd9d588160e89 | |
| ToppCell | droplet-Fat-Mat-18m-Myeloid-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.71e-05 | 161 | 21 | 3 | 8c62ae3fcf304db0f71633e328ceba81a70f03c4 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Myeloid-macrophage|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.71e-05 | 161 | 21 | 3 | f1d258c81bcf0f3c52bd20aa58faa9a5fd888168 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Myeloid-macrophage|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.71e-05 | 161 | 21 | 3 | 787f91f906756ef570c0d02936c3cdfafb3f7454 | |
| ToppCell | AT1_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 5.81e-05 | 162 | 21 | 3 | ae2ba4f21f6f6c512006fa531d670b88be7c04c9 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Myeloid-macrophage|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.81e-05 | 162 | 21 | 3 | db1e09324e9fdd5e571600cff4f2b1c0cb3c179d | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.81e-05 | 162 | 21 | 3 | ec29c6f1c31e41ddcb041a49c593910edaf0532c | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Myeloid-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.81e-05 | 162 | 21 | 3 | 9734943c8b7c04e568792253b7352672a3a5cc58 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Myeloid|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.81e-05 | 162 | 21 | 3 | 48d7bee271f74b5d06c03c6ae06a662d765a6de3 | |
| ToppCell | AT1-AT2_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 5.81e-05 | 162 | 21 | 3 | 57d627259d27f39885bf416d74bcb6656db6e27b | |
| ToppCell | facs-MAT-Fat-3m-Myeloid-myeloid_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.92e-05 | 163 | 21 | 3 | 5fc836444bc156c8248abee001b0ecbe43f980c9 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.92e-05 | 163 | 21 | 3 | a6e272e043859858084b8d4d96fa4ff9e6eca454 | |
| ToppCell | E17.5-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.03e-05 | 164 | 21 | 3 | 4e9de41ea10ce3233c09e144bfc0453c0ae79fd3 | |
| ToppCell | E17.5-Endothelial-lymphatic_endothelial_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.03e-05 | 164 | 21 | 3 | 6f4914b0ac282b4b9f6111930a82515178c1bc80 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Myeloid|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-05 | 165 | 21 | 3 | 518ee34c18065100a2f2c6e407d3a7866b908593 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Myeloid-macrophage|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-05 | 165 | 21 | 3 | c2fc76feff58d77128f5a5318fed9c265574d760 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Myeloid|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-05 | 165 | 21 | 3 | 5f23173ec624ea7f893d22e326446f0e39e30b4e | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Myeloid-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-05 | 165 | 21 | 3 | becb8f726b84509ec29c75b530a3fe757651301d | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Myeloid-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-05 | 165 | 21 | 3 | 1760ec2ac8913a2b33f46672a3f39ca7489966b8 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Myeloid-macrophage|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-05 | 165 | 21 | 3 | ae8dd9c00f96590f27ed21cd6314f4577e00e312 | |
| ToppCell | PCW_07-8.5-Hematologic_ErythroMegGranulo-Hem_Granulocytic-im_mast/basophil_(18)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.25e-05 | 166 | 21 | 3 | f03f78cae6272c89618c0bda032ce45c4fc96baa | |
| ToppCell | Thalamus-Hematopoietic|Thalamus / BrainAtlas - Mouse McCarroll V32 | 6.25e-05 | 166 | 21 | 3 | 76d60ac7ac5d1eaf530f0c741d9c48e0bd58396b | |
| ToppCell | facs-GAT-Fat-24m-Myeloid-myeloid_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.36e-05 | 167 | 21 | 3 | 5d9ffbcb539d9c50cef9dd792ea11aa37dd2c1df | |
| ToppCell | facs-GAT-Fat-24m-Myeloid|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.36e-05 | 167 | 21 | 3 | c31e41fb76ba261ac546fac3cc2b8337e39bfa86 | |
| ToppCell | facs-GAT-Fat-24m-Myeloid-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.36e-05 | 167 | 21 | 3 | a04d1f2413fd24ad5e9cc67312220606157fecf3 | |
| ToppCell | facs-MAT-Fat-24m-Myeloid|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.47e-05 | 168 | 21 | 3 | 6514a27a54ea0f07172b3a73270250143a7b14f0 | |
| ToppCell | facs-MAT-Fat-24m-Myeloid-nan|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.47e-05 | 168 | 21 | 3 | 0b6bb335e93476b13955543eeb487243b0067369 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Hematologic-leukocyte|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.59e-05 | 169 | 21 | 3 | b46e446067c6425bd5b8ef7719aeecff5e861249 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Hematologic|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.59e-05 | 169 | 21 | 3 | 5508b03fbf483fce7701d6c82c297ffda3b1ba05 | |
| ToppCell | facs-Trachea-24m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_tracheal_l12|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.59e-05 | 169 | 21 | 3 | 8180aeda13c511260d0542a94156059d558848a7 | |
| ToppCell | facs-Trachea-3m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_tracheal_l12|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.70e-05 | 170 | 21 | 3 | f524b73d65941ebef7671c46df4362a3f15d24fc | |
| ToppCell | facs-Trachea-nan-18m-Myeloid-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.70e-05 | 170 | 21 | 3 | 774b0c1b453e19651f9481dc6bcabac538c5acb7 | |
| ToppCell | facs-Trachea-18m-Hematologic-myeloid-tracheal_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.70e-05 | 170 | 21 | 3 | e4856e768d0088e42fbdb8e6039f5bc3daa0afdb | |
| ToppCell | facs-Trachea-18m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_tracheal_l12|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.82e-05 | 171 | 21 | 3 | 26755e43d94e934106fc19ab929e4d34c17d6cba | |
| ToppCell | facs-Trachea-18m-Hematologic-myeloid|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.94e-05 | 172 | 21 | 3 | c260680f5455fce133b7b4158b4197fc76115779 | |
| ToppCell | facs-Trachea-nan-3m-Myeloid-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.06e-05 | 173 | 21 | 3 | e4eb2ac2cee16bfa8eabc938f8030ee161c972c5 | |
| ToppCell | facs-Trachea-nan-3m-Myeloid|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.06e-05 | 173 | 21 | 3 | 371515471459307a3b2adce735263b4aac828956 | |
| ToppCell | facs-Trachea-nan-3m-Myeloid-macrophage|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.06e-05 | 173 | 21 | 3 | 4e9b6c71030ae0d63d54e7255e4a10b25970fcc4 | |
| ToppCell | facs-Trachea-24m-Hematologic-myeloid-tracheal_macrophage|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.06e-05 | 173 | 21 | 3 | 7300b1ea8090cc5cd327a7207330eca538c27e63 | |
| ToppCell | PND01-03-samps-Endothelial-Postnatal_endothelial-capillary_endothelial_Hpgd-CA4_high|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 7.18e-05 | 174 | 21 | 3 | cb0109661e8c9ca04d67d33f2d926f0e649bf67d | |
| ToppCell | facs-Trachea-24m-Hematologic-myeloid|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.18e-05 | 174 | 21 | 3 | 2f25fba5225f4687df4396645e94565a640b5583 | |
| ToppCell | facs-Trachea-3m-Hematologic-myeloid-tracheal_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.18e-05 | 174 | 21 | 3 | d67fc8e30cc67fff8f7fdeaccb409d12ca0992c1 | |
| ToppCell | facs-Trachea-3m-Hematologic-myeloid|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.31e-05 | 175 | 21 | 3 | 22fd7d9b4d403cc8061316855f78bad0eb705ce9 | |
| ToppCell | facs-Kidney-nan-18m-Myeloid-macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.31e-05 | 175 | 21 | 3 | cec941edec6849f2fb602c08fd1eed6d0345f934 | |
| ToppCell | facs-Kidney-nan-18m-Myeloid|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.31e-05 | 175 | 21 | 3 | 2cb0d07a47bc645cfa690bb853e11d657af19ede | |
| ToppCell | AT1-AT2_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 7.31e-05 | 175 | 21 | 3 | 9a95ab5c361ebaa8747983c5a0d69025682a19ad | |
| ToppCell | facs-Kidney-nan-18m-Myeloid-macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.31e-05 | 175 | 21 | 3 | 24d58e2f6d36124bde0f2c6f5357b9161bc5f476 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid-CLC+_Mast_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.43e-05 | 176 | 21 | 3 | 183ba1aa5cf594b88ec08e0e41241668b51256a9 | |
| ToppCell | facs-Trachea-3m-Hematologic|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.56e-05 | 177 | 21 | 3 | c9d235fc518b291ed98088a1206d14d6692bc7fd | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Monocytes,_Macrophages|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.56e-05 | 177 | 21 | 3 | cdad5a2f672a7f07c05669bfcaf1ec74defd3de7 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.56e-05 | 177 | 21 | 3 | 991ae76bb615392d84aeb89886148fa42c1c649c | |
| ToppCell | Posterior_cortex-Hematopoietic|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.68e-05 | 178 | 21 | 3 | ea9e4f461dda34c0ebc707d7dbefc7a49ce5bb55 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.68e-05 | 178 | 21 | 3 | 8184a2b9872f7ca12a9823535de485e841aeffb1 | |
| ToppCell | Control-Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.81e-05 | 179 | 21 | 3 | c4ff8b191ed0f6dc2dd784869f6f2c62e170a7db | |
| ToppCell | Control-Myeloid-Monocytes,_Macrophages|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.81e-05 | 179 | 21 | 3 | a79a244bf8ecc333d034b2eb2de554d3310ca6de | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-Myeloid-Macrophages|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.94e-05 | 180 | 21 | 3 | 7af90f0e7ca001bf1fe5c860ee54c4cc8eb483bf | |
| ToppCell | AT1_cells-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 7.94e-05 | 180 | 21 | 3 | e1964002681f80d8d62406b6ee52a01e1829ccf2 | |
| ToppCell | LPS-IL1RA-Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.94e-05 | 180 | 21 | 3 | 97241f62ee133dcb0d4855ffda5dd1349de9f7b2 | |
| ToppCell | LPS-IL1RA-Myeloid-Monocytes,_Macrophages|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.94e-05 | 180 | 21 | 3 | 41896546cd1cc458e08c0d4e19aa4860e5d4fcd6 | |
| ToppCell | AT1-AT2_cells-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 8.07e-05 | 181 | 21 | 3 | ca23ce4f2c7b684d8ddd0e8619b3b696023d75e3 | |
| ToppCell | Control-Myeloid|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.07e-05 | 181 | 21 | 3 | 25170e5285996cc80337d5f86a0255569861ae77 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.07e-05 | 181 | 21 | 3 | cd81bc307e2bc42c1e9b24d5645ab65fa18c6133 | |
| ToppCell | LPS-antiTNF-Myeloid-Monocytes,_Macrophages|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.21e-05 | 182 | 21 | 3 | d5d6bc16458bc665e7ad6669040d79f73f640044 | |
| ToppCell | LPS_only-Myeloid|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.21e-05 | 182 | 21 | 3 | 666ac86ee5f6fa9241ae8d80340743707e54b278 | |
| ToppCell | LPS-antiTNF-Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.21e-05 | 182 | 21 | 3 | 0b59ead4bb4486c7ec2ee90b94ee3a09905612c5 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.34e-05 | 183 | 21 | 3 | 614a1c08cf6d01a4f1ed2fb816cd1a6e0c3207ce | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.48e-05 | 184 | 21 | 3 | c7073d1b2c4fdb154d87678b92a0629c02116972 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.48e-05 | 184 | 21 | 3 | bde4eaabd3e9bdaed23867d23a919b9d84b52d4b | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Myeloid-LYVE1+_Macrophage|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.48e-05 | 184 | 21 | 3 | ba260f8a2e6e510141a6b9c458eb0040acff0352 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.48e-05 | 184 | 21 | 3 | cb15d6bae52c5ec251c2235859dc7e65f630ae23 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.48e-05 | 184 | 21 | 3 | ca940a4f4970285ed284d5517d142abab0682044 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.48e-05 | 184 | 21 | 3 | 1ed558a88215b248431c524ea16f13d9022ae98c | |
| ToppCell | LPS-IL1RA-Myeloid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.61e-05 | 185 | 21 | 3 | 9b5fd87ea9d05e051ff1251578ecfbe5e8652853 | |
| ToppCell | PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_immature_monocyte2_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.75e-05 | 186 | 21 | 3 | cb4ea1bc1427230070e9696baeda7de241c354b1 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.75e-05 | 186 | 21 | 3 | 05c40bac5c0ade8b67b7c2112739466e02dbf22b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Degenerative_Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.75e-05 | 186 | 21 | 3 | b3358e0fa6d845c81e94d56c8575f016621d28ff | |
| ToppCell | LPS-antiTNF-Myeloid|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.75e-05 | 186 | 21 | 3 | 839c6da5244f469461b2e5563e36162b2911cd01 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.89e-05 | 187 | 21 | 3 | 4e0bbef6ba0d1b3e1f8d900d4a9dbd41f09a7bc5 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_migrating_dendritic_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.03e-05 | 188 | 21 | 3 | 8fc15c8b78fdd1a578e34325011bc5a87a8aab31 | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_macrophage|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.18e-05 | 189 | 21 | 3 | 440c422369de1c49112d18cf8c506a2a3a81f6ba | |
| ToppCell | Monocytes-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 9.18e-05 | 189 | 21 | 3 | 2164adbe1b0e8e4d39644546b7dfb19e9ea4f7b9 | |
| ToppCell | PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_macrophage|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 9.18e-05 | 189 | 21 | 3 | a438c64a893d43f781ede42e1c7b615b74dc76ef | |
| Drug | Zwittergent 3-12 | 5.47e-07 | 18 | 21 | 3 | CID000084703 | |
| Drug | AC1LA7UO | 3.30e-06 | 32 | 21 | 3 | CID000483172 | |
| Drug | 5-HIAA | 5.46e-06 | 129 | 21 | 4 | CID000001826 | |
| Drug | Triflupromazine | 8.09e-06 | 5 | 21 | 2 | DB00508 | |
| Drug | SCH 24518 | 8.09e-06 | 5 | 21 | 2 | CID000146265 | |
| Drug | proterguride | 8.09e-06 | 5 | 21 | 2 | CID000071999 | |
| Drug | Sch-38548 | 1.21e-05 | 6 | 21 | 2 | CID000130519 | |
| Drug | Bim23268 | 1.70e-05 | 7 | 21 | 2 | CID005311026 | |
| Drug | flumezapine | 1.70e-05 | 7 | 21 | 2 | CID000043602 | |
| Drug | Ee 581 | 2.26e-05 | 8 | 21 | 2 | CID003036100 | |
| Drug | cabergoline | 2.26e-05 | 8 | 21 | 2 | ctd:C047047 | |
| Drug | BIM 23034 | 2.26e-05 | 8 | 21 | 2 | CID005492589 | |
| Drug | Somatostatin | 2.26e-05 | 8 | 21 | 2 | ctd:D013004 | |
| Drug | ritanserin | 2.35e-05 | 61 | 21 | 3 | CID000005074 | |
| Drug | zenarestat | 2.85e-05 | 65 | 21 | 3 | CID000005724 | |
| Drug | CHEBI:334542 | 2.91e-05 | 9 | 21 | 2 | CID010884046 | |
| Drug | X Bb | 2.91e-05 | 9 | 21 | 2 | CID000445281 | |
| Drug | CHEBI:334375 | 2.91e-05 | 9 | 21 | 2 | CID010476504 | |
| Drug | NIASP | 2.91e-05 | 9 | 21 | 2 | CID006439184 | |
| Drug | Tyr(3)-sms | 2.91e-05 | 9 | 21 | 2 | CID000123864 | |
| Drug | Minaprine | 2.91e-05 | 9 | 21 | 2 | DB00805 | |
| Drug | genistein; Down 200; 1uM; MCF7; HG-U133A | 3.02e-05 | 199 | 21 | 4 | 267_DN | |
| Drug | W-13, hydrochloride; Up 200; 10uM; MCF7; HG-U133A | 3.08e-05 | 200 | 21 | 4 | 643_UP | |
| Drug | Vapreotide | 3.26e-05 | 68 | 21 | 3 | CID000071306 | |
| Drug | Peptavlon | 4.92e-05 | 78 | 21 | 3 | CID000021701 | |
| Drug | S 14506 | 5.32e-05 | 12 | 21 | 2 | CID000131905 | |
| Drug | Chlorprothixene | 5.32e-05 | 12 | 21 | 2 | DB01239 | |
| Drug | HCNO | 5.32e-05 | 12 | 21 | 2 | CID000521293 | |
| Drug | AC1L1JSL | 5.51e-05 | 81 | 21 | 3 | CID000005188 | |
| Drug | Cabergoline-d5 | 5.93e-05 | 83 | 21 | 3 | CID000002512 | |
| Drug | Edotreotide | 6.28e-05 | 13 | 21 | 2 | CID000158782 | |
| Drug | Sordinol | 6.28e-05 | 13 | 21 | 2 | CID000012453 | |
| Drug | Calcium | 7.12e-05 | 493 | 21 | 5 | ctd:D002118 | |
| Drug | Lisuride | 7.32e-05 | 14 | 21 | 2 | DB00589 | |
| Drug | Pramipexole | 7.32e-05 | 14 | 21 | 2 | DB00413 | |
| Drug | SRA 880 | 7.32e-05 | 14 | 21 | 2 | CID005311376 | |
| Drug | Ropinirole | 7.32e-05 | 14 | 21 | 2 | DB00268 | |
| Drug | A 86929 | 8.45e-05 | 15 | 21 | 2 | ctd:C095427 | |
| Drug | L-817,818 | 8.45e-05 | 15 | 21 | 2 | CID005311375 | |
| Drug | Cabergoline | 8.45e-05 | 15 | 21 | 2 | DB00248 | |
| Drug | Apomorphine | 8.45e-05 | 15 | 21 | 2 | DB00714 | |
| Drug | L-796,778 | 9.65e-05 | 16 | 21 | 2 | CID005311373 | |
| Drug | Pergolide | 9.65e-05 | 16 | 21 | 2 | ctd:D010479 | |
| Drug | aporphine | 1.09e-04 | 17 | 21 | 2 | CID000114911 | |
| Drug | Pergolide | 1.09e-04 | 17 | 21 | 2 | DB01186 | |
| Drug | spirodecanone | 1.23e-04 | 18 | 21 | 2 | CID000070556 | |
| Drug | L-803,087 | 1.23e-04 | 18 | 21 | 2 | CID005311374 | |
| Drug | Cycam | 1.23e-04 | 18 | 21 | 2 | CID000122080 | |
| Drug | pasireotide | 1.23e-04 | 18 | 21 | 2 | ctd:C517782 | |
| Drug | Bromocriptine | 1.23e-04 | 18 | 21 | 2 | DB01200 | |
| Drug | Nozinan | 1.23e-04 | 18 | 21 | 2 | CID000003916 | |
| Drug | tiospirone | 1.37e-04 | 19 | 21 | 2 | CID000055751 | |
| Drug | NSC186067 | 1.37e-04 | 19 | 21 | 2 | CID000004140 | |
| Drug | S-20499 | 1.37e-04 | 19 | 21 | 2 | CID000121851 | |
| Drug | quinagolide | 1.37e-04 | 19 | 21 | 2 | CID000055645 | |
| Drug | butyrophenone | 1.37e-04 | 19 | 21 | 2 | CID000010315 | |
| Drug | RP 62203 | 1.37e-04 | 19 | 21 | 2 | CID000060785 | |
| Drug | SB 200646A | 1.37e-04 | 19 | 21 | 2 | CID000126769 | |
| Drug | SCH 39166 | 1.52e-04 | 20 | 21 | 2 | CID000107930 | |
| Drug | 2,5-dimethoxy-4-iodoamphetamine | 1.64e-04 | 117 | 21 | 3 | CID000001229 | |
| Drug | L-779,976 | 1.68e-04 | 21 | 21 | 2 | CID005311372 | |
| Drug | Gadolinium | 1.68e-04 | 21 | 21 | 2 | ctd:D005682 | |
| Drug | Photofrin | 1.68e-04 | 21 | 21 | 2 | CID000057166 | |
| Drug | NSC186061 | 1.69e-04 | 118 | 21 | 3 | CID000004163 | |
| Drug | BP 897 | 1.85e-04 | 22 | 21 | 2 | CID003038494 | |
| Drug | setoperone | 1.85e-04 | 22 | 21 | 2 | CID000068604 | |
| Drug | Lanthanum | 1.85e-04 | 22 | 21 | 2 | ctd:D007811 | |
| Drug | perazine | 2.03e-04 | 23 | 21 | 2 | CID000004744 | |
| Drug | ANB-NOS | 2.03e-04 | 23 | 21 | 2 | CID003080866 | |
| Drug | DL-tryptophan | 2.05e-04 | 126 | 21 | 3 | CID000001148 | |
| Drug | ketanserin | 2.29e-04 | 131 | 21 | 3 | CID000003822 | |
| Drug | Inositol 1,4,5-Trisphosphate | 2.40e-04 | 25 | 21 | 2 | ctd:D015544 | |
| Drug | butamifos | 2.60e-04 | 26 | 21 | 2 | CID000037419 | |
| Drug | tardan | 2.60e-04 | 26 | 21 | 2 | CID000002729 | |
| Drug | Rc 121 | 2.60e-04 | 26 | 21 | 2 | CID000127388 | |
| Drug | triflupromazine | 2.80e-04 | 27 | 21 | 2 | CID000005568 | |
| Drug | NSC169490 | 2.80e-04 | 27 | 21 | 2 | CID004210613 | |
| Drug | ergolines | 2.80e-04 | 27 | 21 | 2 | CID003083577 | |
| Drug | fluperlapine | 2.80e-04 | 27 | 21 | 2 | CID000049381 | |
| Drug | eniluracil | 2.80e-04 | 27 | 21 | 2 | CID000043157 | |
| Drug | L-741,626 | 3.02e-04 | 28 | 21 | 2 | CID000133633 | |
| Drug | dtpa-sms | 3.02e-04 | 28 | 21 | 2 | CID000072128 | |
| Drug | roxindole | 3.02e-04 | 28 | 21 | 2 | CID000219050 | |
| Drug | NSC407316 | 3.02e-04 | 28 | 21 | 2 | CID000003067 | |
| Drug | prochlorperazine | 3.24e-04 | 29 | 21 | 2 | CID000004917 | |
| Drug | AC1L1G8Z | 3.47e-04 | 30 | 21 | 2 | CID000003581 | |
| Drug | Tt 232 | 3.47e-04 | 30 | 21 | 2 | CID000164469 | |
| Drug | mesulergine | 3.71e-04 | 31 | 21 | 2 | CID000068848 | |
| Drug | AN-201 | 3.71e-04 | 31 | 21 | 2 | CID000119196 | |
| Drug | 111In-pentetreotide | 3.71e-04 | 31 | 21 | 2 | CID003081912 | |
| Drug | Anidulafungin | 3.91e-04 | 157 | 21 | 3 | CID000166548 | |
| Drug | YM-09151-2 | 3.95e-04 | 32 | 21 | 2 | CID000004452 | |
| Drug | mesoridazine | 4.20e-04 | 33 | 21 | 2 | CID000004078 | |
| Drug | CGS 8216 | 4.20e-04 | 33 | 21 | 2 | CID000104916 | |
| Drug | pirenperone | 4.20e-04 | 33 | 21 | 2 | CID000004847 | |
| Drug | Depixol | 4.20e-04 | 33 | 21 | 2 | CID000017011 | |
| Drug | ropinirole | 4.20e-04 | 33 | 21 | 2 | CID000005095 | |
| Drug | transdihydrolisuride | 4.47e-04 | 34 | 21 | 2 | CID000005406 | |
| Drug | CGS 12066B | 4.47e-04 | 34 | 21 | 2 | CID000002689 | |
| Drug | Amitriptyline | 4.52e-04 | 165 | 21 | 3 | ctd:D000639 | |
| Disease | MHPG measurement, 5-HIAA measurement | 6.52e-05 | 17 | 21 | 2 | EFO_0005132, EFO_0005133 | |
| Disease | Parkinson's disease (implicated_via_orthology) | 1.83e-04 | 157 | 21 | 3 | DOID:14330 (implicated_via_orthology) | |
| Disease | neutrophil count, eosinophil count | 4.48e-04 | 213 | 21 | 3 | EFO_0004833, EFO_0004842 | |
| Disease | neutrophil percentage of leukocytes | 8.18e-04 | 610 | 21 | 4 | EFO_0007990 | |
| Disease | Petit mal status | 1.04e-03 | 67 | 21 | 2 | C0270823 | |
| Disease | Status Epilepticus, Subclinical | 1.04e-03 | 67 | 21 | 2 | C0751522 | |
| Disease | Simple Partial Status Epilepticus | 1.04e-03 | 67 | 21 | 2 | C0751524 | |
| Disease | Non-Convulsive Status Epilepticus | 1.04e-03 | 67 | 21 | 2 | C0751523 | |
| Disease | Grand Mal Status Epilepticus | 1.04e-03 | 67 | 21 | 2 | C0311335 | |
| Disease | Complex Partial Status Epilepticus | 1.04e-03 | 67 | 21 | 2 | C0393734 | |
| Disease | Status Epilepticus | 1.07e-03 | 68 | 21 | 2 | C0038220 | |
| Disease | Amphetamine Abuse | 1.30e-03 | 75 | 21 | 2 | C0236807 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MWCPFFITNITLVLC | 336 | P41595 | |
| CTFMQIVICVIWLYT | 731 | P41180 | |
| VIMGVFVCCWLPFFI | 276 | P21728 | |
| IWVVAFVMCIPVFVY | 146 | Q16581 | |
| WDMCNYLVPACIVVL | 1586 | Q8IZY2 | |
| NTILFSMCRVPVVCW | 386 | Q86W28 | |
| ILYKACQVPGICWVV | 346 | Q86W26 | |
| VGCLCVVYVLVVIWA | 1351 | Q7Z442 | |
| IFTFLVCWMPYIVIC | 261 | Q9H1Y3 | |
| VCWMPYIVICFLVVN | 266 | Q9H1Y3 | |
| VILMIPIAVCIYWIN | 256 | Q7KYR7 | |
| FTMCFIPLVCWIVCT | 406 | Q96P20 | |
| VICWMPFYVVQLVNV | 281 | P30872 | |
| LWMVCTVLAVFIICF | 231 | P25105 | |
| VVFVLCWMPFYVVQL | 266 | P31391 | |
| VVLMCFVVPTLVPWY | 196 | Q86SK9 | |
| CTVWTCVIIVCKMLY | 986 | Q9H5I5 | |
| VLMCILTAYVLCWAP | 276 | Q8NFJ6 | |
| QCFLVVVALLCVPWM | 636 | Q93050 | |
| CWVLYLDPTLCVVMV | 311 | Q9Y6M5 | |
| KGILCMFPWQCVVYV | 46 | Q9H354 | |
| LVPYLVCFMWCELSV | 531 | O76024 | |
| CFAIVNVVCFIQPYW | 46 | Q86UP9 |